Standard Biotools (LAB) Change in Accured Expenses (2016 - 2025)
Standard Biotools (LAB) has disclosed Change in Accured Expenses for 16 consecutive years, with $98000.0 as the latest value for Q4 2025.
- Quarterly Change in Accured Expenses fell 98.13% to $98000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, up 1170.8% year-over-year, with the annual reading at $10.4 million for FY2025, 1170.8% up from the prior year.
- Change in Accured Expenses for Q4 2025 was $98000.0 at Standard Biotools, down from $10.1 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $10.1 million in Q3 2025, with the low at -$8.0 million in Q3 2021.
- Average Change in Accured Expenses over 5 years is -$83736.8, with a median of $11000.0 recorded in 2024.
- The sharpest move saw Change in Accured Expenses plummeted 2991.56% in 2024, then soared 112300.0% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$8.0 million in 2021, then soared by 81.94% to -$1.4 million in 2022, then crashed by 273.0% to -$5.4 million in 2023, then surged by 197.17% to $5.2 million in 2024, then crashed by 98.13% to $98000.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods came in at $98000.0, $10.1 million, and $7.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.